APA (7th ed.) Citation

Díaz-Cerezo, S., Artime, E., Redondo-Antón, J., Duque, N., Spaepen, E., Cruz, M. Á. M., . . . Santos, M. R. (2025). Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study. Patient Preference & Adherence, 19, 1231. https://doi.org/10.2147/PPA.S509483

Chicago Style (17th ed.) Citation

Díaz-Cerezo, Silvia, et al. "Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide Versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study." Patient Preference & Adherence 19 (2025): 1231. https://doi.org/10.2147/PPA.S509483.

MLA (9th ed.) Citation

Díaz-Cerezo, Silvia, et al. "Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide Versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study." Patient Preference & Adherence, vol. 19, 2025, p. 1231, https://doi.org/10.2147/PPA.S509483.